An untargeted metabolomics study of blood pressure: findings from the Bogalusa Heart Study-Reference-Cited by-同舟云学术

An untargeted metabolomics study of blood pressure: findings from the Bogalusa Heart Study

Published:2020-01-30 Issue:7 Volume:38 Page:1302-1311
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

He William J.,Li Changwei,Mi Xuenan,Shi Mengyao,Gu Xiaoying,Bazzano Lydia A.,Razavi Alexander C.,Nierenberg Jovia L.,Dorans Kirsten,He Hua,Kelly Tanika N.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference48 articles.

1. Selected major risk factors and global and regional burden of disease;Ezzati;Lancet,2002

2. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mmHg, 1990–2015;Forouzanfar;JAMA,2017

3. Global burden of hypertension: analysis of worldwide data;Kearney;Lancet,2005

4. Heart Disease and Stroke Statistics—2015 Update;Mozaffarian;Circulation,2015

5. Omics of blood pressure and hypertension;Arnett;Circ Res,2018

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Metabolites Associated With Blood Pressure After Dietary Interventions;Hypertension;2024-09

2. Unique intestinal microflora and metabolic profile in different stages of hypertension reveal potential biomarkers for early diagnosis and prognosis;Journal of Medical Microbiology;2024-08-30

3. Identification of Chagas disease biomarkers using untargeted metabolomics;Scientific Reports;2024-08-13

4. Circulating Metabolite Profiles and Risk of Coronary Heart Disease Among Racially and Geographically Diverse Populations;Circulation: Genomic and Precision Medicine;2024-08

5. Causal association between blood metabolites and risk of hypertension: a Mendelian randomization study;Frontiers in Cardiovascular Medicine;2024-06-07